Compare
Crawford & Co vs SelectQuote, Inc. vs CorVel Corp vs eHealth, Inc.
| Latest fiscal year | Crawford & Co CRD-A | SelectQuote, Inc. SLQT | CorVel Corp CRVL | eHealth, Inc. EHTH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| Revenue | $1.31B | $1.62B | $958.53M | $554.01M |
| Revenue growth (YoY) | -2.2% | +6.0% | +7.0% | +4.1% |
| Gross margin | n/a | n/a | 24.3% | 43.5% |
| Operating margin | n/a | 4.6% | n/a | 12.0% |
| Net margin | 1.5% | 3.8% | 11.5% | 7.2% |
| Net income | $19.63M | $62.19M | $110.34M | $40.04M |
| EPS (Diluted) | n/a | -$0.06 | $2.14 | -$0.34 |
| Operating cash flow | $101.85M | $31.89M | $155.64M | -$25.34M |
| Free cash flow | $94.83M | $27.61M | $110.28M | -$27.59M |
| Cash & equivalents | $64.08M | $16.03M | $233.07M | $73.72M |
| Total assets | $764.30M | $1.29B | $642.99M | $1.26B |
| Total liabilities | n/a | $636.80M | $248.75M | $288.82M |
| Shareholders' equity | $171.43M | $351.81M | $394.23M | $591.60M |
| Return on year-end equity | 11.5% | 17.7% | 28.0% | 6.8% |
| Shares outstanding | n/a | 176.47M | 50.91M | 30.99M |
Revenue, most recent five fiscal years
| Fiscal year | Crawford & Co | SelectQuote, Inc. | CorVel Corp | eHealth, Inc. |
|---|---|---|---|---|
| Latest | $1.31B Ended 2025-12-31 | $1.62B Ended 2026-06-30 | $958.53M Ended 2026-03-31 | $554.01M Ended 2025-12-31 |
| 1 year earlier | $1.34B Ended 2024-12-31 | $1.53B Ended 2025-06-30 | $895.59M Ended 2025-03-31 | $532.41M Ended 2024-12-31 |
| 2 years earlier | $1.32B Ended 2023-12-31 | $1.32B Ended 2024-06-30 | $795.31M Ended 2024-03-31 | $452.87M Ended 2023-12-31 |
| 3 years earlier | $1.23B Ended 2022-12-31 | $1.00B Ended 2023-06-30 | $718.56M Ended 2023-03-31 | $405.36M Ended 2022-12-31 |
| 4 years earlier | $1.14B Ended 2021-12-31 | $764.04M Ended 2022-06-30 | $646.23M Ended 2022-03-31 | $538.20M Ended 2021-12-31 |